D-Arginine Monohydrochloride

We are D-Arginine Monohydrochloride CAS:627-75-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Solubility in water	Colorless & clear (c=5)
Specific rotation [α]D20	-22.1°～-22.9°(c= 8, 6M-HCl)
Loss on drying	Not more than 0.3%
Residue on ignition (as sulfate)	Not more than 0.1%
Sulfate (SO4)	Not more than 0.03%
Heavy metals (as Pb)	Not more than 10ppm
Iron (Fe)	Not more than 10ppm
Ammonium (NH4)	Not more than 0.02%
Arsenic (As2O3)	Not more than 1ppm
Other amino acids	Not detected by T.L.C.(The spotted amount, 20μg)
Assay	98.5%～101.0%
L-Isomer	Not more than 0.5%

Related News: Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.2,2,3,3,3-Pentafluoropropan-1-amine CAS:422-03-7 At present, China’s bulk drug industry is mainly focused on bulk drug substances, and there is huge room for development in terms of specialty drug substances and patented drug substances.2,3-Difluoro-5-methylbenzonitrile CAS:1003712-18-2 At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.Clorhidrato de 5-amino-1H-imidazol-4-carboxamida CAS:72-40-2 At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.Under the high pressure of environmental protection, if Chinese API companies want to achieve sustainable operation, they must recognize the current situation, increase environmental investment, and carry out industrial upgrades, focusing on new product development, process improvement, CMO business and new technology research. And other businesses to carry out work to improve safety, environmental protection, quality, cost and other capabilities, so as to seize structural opportunities.